RALEIGH, N.C., May 31, 2011 /PRNewswire/ -- Today, Campbell Alliance released the results of its Oncology National Commercial
The ONC Study explores the factors that have caused major changes in the oncology market over the past 10 years and evaluates how those factors will continue to shape the market during the next decade. It also provides recommendations on how pharmaceutical and biotech companies should manage the increasingly challenging oncology market environment.
To gather information for the study, Campbell Alliance interviewed decision makers from 9 of the world's top-20 pharmaceutical and biotech companies, a range of national and regional payer organizations, and several integrated delivery systems, as well as 10 oncology key opinion leaders and 20 community hematologists/oncologists.
According to Jeff Stewart, one of the study's authors, "We felt it was the right time to document how much oncology has changed over the past decade and take a look forward. In truth, the extent of change has been breathtaking. New therapies are only the beginning of the story. Oncologists have changed. Payers have changed. Sales forces have changed. Medicare has changed. Financial incentives have changed, and patients have changed. It's a different world, and it continues to evolve."
The study outlined 10 key trends that will shape the market for years to come. Five of the trends relate to product development, while the other five relate to commercial issues. The study's report indicates that these trends—when their effects are combined—are bringing about a "perfect storm" in oncology that will make the environment far more challenging for pharmaceutical and biotech firms. According to the report's authors, the study's objective is to help industry decision makers understand the drivers of change within their environment and begin developing strategies that will help their companies thrive in a market that will only get more challenging over the next few years.
About Campbell Alliance
Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Medical Affairs, and Sales. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and Zug, Switzerland, the firm serves clients throughout North America, Europe, and Japan.
For Campbell Alliance:James ForteCampbell Alliance919-844-7100 ext. firstname.lastname@example.org
SOURCE Campbell Alliance
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All